DNV-10698-63675
4 vaccinations
7 coded responses
23 check-ins
6 free-text entries
6 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 307 / GA
- Registered
- 2021-04-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-15
Dose 1 — Pfizer-BioNTech
-
2021-04-05
Dose 2 — Pfizer-BioNTech
-
2021-04-06
Registered in v-safe
-
2021-04-06
Survey response — days 1–6 daily, dose 2MedDRA: Formication, Paraesthesia — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Skin crawling, dizzy, fingers tinglingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-06
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-07
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite, Palpitations — Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Heart palpitations, loss of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-08
-
2021-04-09
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Good · Site: PainFree text: Complete loss of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: GoodFree text: Im back to normal but it took the better part of a week and Im a fit healthy adult. This vaccine may not affect everyone but it was rough on me.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-05
- 2021-10-04
-
2021-10-21
Dose 3 — Pfizer-BioNTech
-
2022-03-18
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-04-05
Survey response — 12 months, dose 2MedDRA: COVID-19, Gastrointestinal bacterial overgrowth, Gastrointestinal disorder, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Since having Covid in January I am having trouble with my GI tract. I'm currently on antibiotics for SIBO · Healthcare visit (other): Have an appointment in May with a GI doc.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-05
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-12
-
2022-04-25
Dose 4 — Pfizer-BioNTech
-
2022-04-25
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-04-26
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2022-04-26
Report sent to call center — days 1–6 daily, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-27
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-27
Call successfulDoes not wish to fill out VAERS report
-
2022-04-28
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-29
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-04-30
- 2022-05-01
- 2022-05-02
- 2022-05-09
- 2022-05-16
- 2022-05-23
- 2022-05-30
- 2022-06-06
-
2022-07-25
Survey response — 3 months, dose 4MedDRA: Abdominal pain — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Pretty severe abdominal pain several hrs post mealsMedDRA releases: 2024-11 · check-in free text available
-
2022-07-25
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-26
-
2022-08-08
Call successfulParticipant prefers to complete VAERS report online
-
2023-04-25
Survey response — 12 months, dose 4MedDRA: Asthenia, Decreased appetite, Loss of personal independence in daily activities, Pain, Pancreatic failure, Pre-existing disease, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-25
Report sent to call center — 12 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-04-26
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Pfizer-BioNTech | |
| 2 | 2021-04-05 | Pfizer-BioNTech | |
| 3 | 2021-10-21 | Pfizer-BioNTech | No |
| 4 | 2022-04-25 | Pfizer-BioNTech | No |
Call center
6 call center cases
6 successful
VAERS report filed, before or during a call: 2
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Skin crawling, dizzy, fingers tingling
Systemic reaction (other): Heart palpitations, loss of appetite
Systemic reaction (other): Complete loss of appetite
Systemic reaction (other): Im back to normal but it took the better part of a week and Im a fit healthy adult. This vaccine may not affect everyone but it was rough on me.
Release 11 — 12 months, dose 2
Symptoms: Since having Covid in January I am having trouble with my GI tract. I'm currently on antibiotics for SIBO
Healthcare visit (other): Have an appointment in May with a GI doc.
Release 12 — 3 months, dose 4
Symptoms: Pretty severe abdominal pain several hrs post meals
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Abdominal pain | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Gastrointestinal bacterial overgrowth | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Loss of personal independence in daily activities | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pancreatic failure | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Formication | ✓ | ✓ | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release